58
Participants
Start Date
April 3, 2014
Primary Completion Date
May 23, 2016
Study Completion Date
May 23, 2016
Atorvastatin 20 mg
The patients who meet the 2013 American College of Cardiology/American Heart Association criteria for receiving lipid-lowering therapy will be randomized into 5 groups.
Cholestyramine 8 g
The patients who meet the 2013 American College of Cardiology/American Heart Association criteria for receiving lipid-lowering therapy will be randomized into 5 groups.
Omega-3 2g
The patients who meet the 2013 American College of Cardiology/American Heart Association criteria for receiving lipid-lowering therapy will be randomized into 5 groups.
Concurrent with Atorvastatin 5 mg + Ezetimibe 10 mg
The patients who meet the 2013 American College of Cardiology/American Heart Association criteria for receiving lipid-lowering therapy will be randomized into 5 groups.
Lifestyle modification
The patients who meet the 2013 American College of Cardiology/American Heart Association criteria for receiving lipid-lowering therapy will be randomized into 5 groups.
Division of Cardiology, Department of Internal Medicine,, Seoul
Yonsei University
OTHER